Yi W. Lim
Singapore, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Decentralised germline genetic testing for epithelial ovarian cancer in a tertiary Asian centre.
Journal: Annals of the Academy of Medicine, Singapore
Published: April 13, 2026
Pembrolizumab plus lenvatinib in recurrent gynaecological clear cell carcinoma (LARA): a multicentre, single-arm, phase 2 trial.
Journal: The Lancet. Oncology
Published: August 21, 2025
Durvalumab versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): A Multicenter, Randomized, Phase 2 Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 16, 2025
Clinical and biological characteristics associated with loss-of-heterozygosity in endometrial cancer.
Journal: Journal of gynecologic oncology
Published: November 28, 2024
Scalp cooling therapy for chemotherapy-induced hair loss in patients with breast or gynecological cancers-an Asian tertiary institution experience.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: February 19, 2024
Molecular profiling of metastatic breast cancer and target-based therapeutic matching in an Asian tertiary phase I oncology unit.
Journal: Frontiers in oncology
Published: November 21, 2023
Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experience.
Journal: Journal of gynecologic oncology
Published: May 07, 2023
Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 30, 2021
PD-L1 Expressing Recurrent Clear Cell Carcinoma of the Vulva with Durable Partial Response to Pembrolizumab: A Case Report.
Journal: OncoTargets and therapy
Published: March 08, 2021
Phase 1 Study of Low-Dose Fractionated Whole Abdominal Radiation Therapy in Combination With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer (GCGS-01).
Journal: International journal of radiation oncology, biology, physics
Published: August 25, 2020
Reversal of Bowel Obstruction With Platinum-Based Chemotherapy and Olaparib in Recurrent, Short Platinum-Free Interval, RAD51C Germline Mutation-Associated Ovarian Cancer.
Journal: JCO precision oncology
Published: November 01, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026